Health Care

3 charities cancel Mar-a-Lago events amid Trump backlash

A leading U.S. hospital pulled its annual fundraiser from Donald Trump's Mar-a-Lago resort on Thursday, reversing course after initially resisting pressure from health professionals and others over the president's support for repealing the Affordable Care Act and cutting federal budget dollars to medical research.

EpiPen maker finalizes settlement for government overcharges

EpiPen maker Mylan has finalized a $465 million federal agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade — charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government.

The Latest: France issues list of products with tainted eggs

The Latest on the scandal in Europe over eggs, poultry and egg products contaminated with the pesticide Fipronil (all times local): 6:15 p.m. France's government, facing pressure for more transparency amid Europe's egg scandal, has released a list of products pulled from supermarkets because they were made with pesticide-tainted eggs.

Mylan, U.S. finalize $465 million EpiPen settlement

Mylan NV has finalized a $465 million settlement with the U.S. Justice Department, resolving claims it overcharged the government for its EpiPen emergency allergy treatment, which became the center of a firestorm over price increases.

Trump's ObamaCare subsidy indecision triggers uncertainty over health care costs

Insurers’ final deadline to file rate requests or adjustments for 2018 in many states was pushed back to September as uncertainty over both health care policy and the future of key ObamaCare subsidy payments unnerves health companies deciding whether to continue offering plans on the federal marketplace and what to charge for them.

UnitedHealth CEO Stephen Hemsley to step down

UnitedHealth Group Inc's chief executive, Stephen Hemsley, is stepping down and will be succeeded by President David Wichmann, the largest U.S. health insurer said on Wednesday.

Report: Higher premiums if Trump halts 'Obamacare' subsidies

Premiums for a popular type of individual health care plan would rise sharply, and more people would be left with no insurance options if President Donald Trump makes good on his threat to stop "Obamacare" payments to insurers, the Congressional Budget Office says.

Report: Higher premiums if Trump halts 'Obamacare' subsidies

Premiums for a popular type of individual health plan would rise sharply, and more people would be left with no insurance options if President Donald Trump makes good on his threat to stop "Obamacare" payments to insurers, the Congressional Budget Office said Tuesday.